Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP749 for overactive bladder
ACTRN12605000584639Phase 2Recruiting
- Sponsor
- UroGen Pharma
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of besipirdine in overactive bladder (OAB) (2 arms), sponsored by UroGen Pharma. Started Aug 2006; status: recruiting.
02
Drugs
besipirdine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ACTRN12605000584639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000584639.